Fundamental Shifts in Research, Ethics and Peer Review in the Era of the COVID-19 Pandemic.


Journal

Journal of Korean medical science
ISSN: 1598-6357
Titre abrégé: J Korean Med Sci
Pays: Korea (South)
ID NLM: 8703518

Informations de publication

Date de publication:
23 Nov 2020
Historique:
received: 23 10 2020
accepted: 02 11 2020
entrez: 24 11 2020
pubmed: 25 11 2020
medline: 15 12 2020
Statut: epublish

Résumé

The era of the coronavirus disease 2019 (COVID-19) pandemic has led to fundamental shifts in research, ethics, and peer review including reframing of the research design, adapting methodologies to the study type, transitioning of research mechanics, changing research methodologies, overcoming data collection and standardization constraints, upholding research standards and ethics, maintaining informativeness and social value, and providing guarded peer review flexibility. Indeed, the COVID-19 crisis, despite disrupting research worldwide to an unprecedented degree, has also become a catalyst to develop strategies of adaptation to this disruption. As the COVID-19 pandemic continuous to evolve, new, cost-effective, and highly flexible research models need to be developed. Planning is crucial for ensuring short-term and long-term contingency funds to support research logistics and personnel. A mental shift must accompany changes in methodologies to mentor and support researchers who are vital to the continuity of high-caliber research in the long term. A global research perspective through interinstitutional and interprofessional collaboration will sustain adherence to the highest standards of data collection and research reporting.

Identifiants

pubmed: 33230986
pii: 35.e395
doi: 10.3346/jkms.2020.35.e395
pmc: PMC7683245
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e395

Informations de copyright

© 2020 The Korean Academy of Medical Sciences.

Déclaration de conflit d'intérêts

The authors have no potential conflicts of interest to disclose.

Références

J Clin Invest. 2020 Jun 1;130(6):2745-2748
pubmed: 32243259
J Korean Med Sci. 2020 May 25;35(20):e138
pubmed: 32449322
Science. 2020 May 1;368(6490):476-477
pubmed: 32327600
Nature. 2020 Jun;582(7811):162-164
pubmed: 32504014
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Rheumatol Int. 2020 Dec;40(12):2023-2030
pubmed: 33048199
J Korean Med Sci. 2020 Jul 13;35(27):e256
pubmed: 32657090
JAMA Netw Open. 2020 Sep 1;3(9):e2020335
pubmed: 32940678
Pediatr Res. 2020 Aug;88(2):148-150
pubmed: 32544922
AIDS Behav. 2020 Aug;24(8):2232-2235
pubmed: 32303924
PLoS One. 2020 Oct 6;15(10):e0240123
pubmed: 33022014
J Korean Med Sci. 2020 Oct 19;35(40):e331
pubmed: 33075853
J Med Educ Curric Dev. 2020 Aug 27;7:2382120520951819
pubmed: 32923673
N Engl J Med. 2020 Aug 6;383(6):510-512
pubmed: 32283003
Rheumatol Int. 2020 Feb;40(2):183-190
pubmed: 31863133
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Clin Rheumatol. 2020 Nov;39(11):3215-3222
pubmed: 32939569

Auteurs

Edward Barroga (E)

Department of General Education, Graduate School of Nursing Science, St. Luke's International University, Tokyo, Japan. edward-barroga@slcn.ac.jp.

Glafera Janet Matanguihan (GJ)

Department of Biological Sciences, Messiah University, Mechanicsburg, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH